News
Signatures Have Been Signed For a Domestic Biotechnological Drug to Be Used in the Treatment of a Rare Disease
The cell developed by Izmir Biomedicine and Genome Center (IBG) and OzBio LLC will be used for the manufacturing of the drug. With the proje...
Have you visited Our Digital Platform for Healthcare Professionals, NOBELYUM?
Our digital platform NOBELYUM that we implemented as Nobel İlaç as of September, continues to provide an uninterrupted medical and scientific service to healthcare professio...
Nobel İlaç Awarded for the Second Time with the Career Prescription Internship Program
Our Career Recipe internship program was awarded in the TOP 100 Talent Program in 2021, after 2020.
Our Digital Platform for Healthcare Professionals, Nobelyum, is online
As Nobel İlaç, we launched our digital platform, which we built under the name NOBELYUM, in July and put it at the service of healthcare professionals. Providing a continuous, sust...
We become a hope for our forests. We donate a sapling for each of our domestic and foreign employees.
We are all deeply saddened by the fires in many parts of our country.
Nobels of the Year Plaques Found Their Owners
We delivered the plaques of 2019, which we could not give last year due to the pandemic, to the owners in a face-to-face ceremony on Friday, July 9, 2021.
Nobel İlaç's Rise in the Companies Ranking Continues
Nobel İlaç, which continued its rise to 239th place in the "ISO-Turkey's 500 Largest Industrial Enterprises" survey, rose 20 places to 296th place in the "Fortune 500" survey, which determines Turke...
Our virus-like particles (VLP) vaccine is in Phase II stage
COVIBEL, the innovative local Corona Virus vaccine, which is on the vaccine candidate list of the World Health Organization, produced at the biotechnological pharmaceutical raw material facil...
Nobel İlaç was among the top three pharmaceutical companies in R&D investment
The results of the research of Turkey's 250 companies with the highest R&D expenditures have been announced.
Nobel İlaç won the second prize in the “IKMIB (Istanbul Chemicals and Chemical Products Exporters Association) 2020 Stars of Exports Awards, Pharmaceutical Products” category
The export stars of 2020 were determined in the chemical industry, which mak...
Be Understanding Our WEB Site Opened
Prevention starts with understanding! "Halden Anlamak (Be Understanding)" is a social responsibility project that is realized with the unconditional contributions of Nobel İlaç and supports the communication betwee...
We Won Our 3rd Prize with Our Smiling Masks Project
At the PRIDA Communication Awards organized by the Communication Consultancy Companies Association (IDA), we were awarded 1st place in the Digital and Social Media Communication, User Generated Conte...
We took part in The New York Times with our vaccination study
We proudly share with you our work that creates value for health.
We Are Together For Rare Diseases
We said "We are together for rare diseases” and talked about Rare diseases in Instagram live stream moderated by Derya Baykal.
Our Pharma Commercial Group Director, Karin Soydan, was listed among Turkey's 50 Most Influential CMOs
We are proud to announce that Nobel Medicine Pharma Commercial Group Director Karin Soydan was listed among Turkey's most influential 50 CMOs in Tur...
Studies for Domestic Vaccine Are Continued Without Slowing Down at Nobel İlaç
Our Director of Biotechnology and New Product Assessment, Hasan Ersin Zeytin, MD, told TRT Haber about the vaccination activities carried out by Nobel İlaç.
Varank, Minister of Industry, Visited Our Biotechnological Pharmaceutical Plant in TÜBİTAK Marmara Teknokent
Visiting the Nobel İlaç Biotechnology Facility, Mustafa Varank, Minister of Industry and Technology, Mehmet Fatih Kaçır, Deputy Minister, Hasa...
Year-End Meeting of Nobel İlaç Has Started: We Are Connected To Each Other!
2020 has been an odd year for all of us. The epidemic has affected our lives and our ways of doing business, and continues to do so.
